Researchers at Brigham And Womens Hospital (BWH) report that an injectible gel may, in the future, provide relief for patients with RA and OA. There are over 25 million people in the US alone who suffer from RA and/or OA. The BWH report states that the gel could be used to release medicine in reponse to enzymes in the affected joint.
Jeffrey Karp, who lead the research on this gel and who is co-director of the Center for Regenerative Therapeutics at BWH said that the gel could have...
